Skip to main content
. Author manuscript; available in PMC: 2022 Mar 28.
Published in final edited form as: Nat Cancer. 2021 Mar;2(3):253–255. doi: 10.1038/s43018-021-00189-6

Figure 1:

Figure 1:

In long-term melanoma survivors, tracking of tumor-infiltrating CD8+ T cell clonotypes over years reveals their persistence as tissue-resident memory cells with effector capabilities (TRM-IFN) in vitiligo-affected skin and as effector memory T cells (TEM) circulating in the blood. TRM-IFN subset was the most significant positive prognostic indicator relative to the other TRM subsets, TRM-TOX and TRM-JUN, with features of exhaustion, and TCR activation, respectively.